{"id":1618,"date":"2025-01-26T11:19:43","date_gmt":"2025-01-26T05:49:43","guid":{"rendered":"https:\/\/gaainfo.com\/?p=1618"},"modified":"2025-01-26T11:19:43","modified_gmt":"2025-01-26T05:49:43","slug":"piramal-pharma-share-price-target","status":"publish","type":"post","link":"https:\/\/gaainfo.com\/piramal-pharma-share-price-target\/","title":{"rendered":"Piramal Pharma Share Price Target 2025-2030 Today Update, Business Profile, Fundamentals &#038; Quarterly Results"},"content":{"rendered":"<p>The Piramal Group of businesses includes Piramal Pharma, which is registered in Mumbai, Maharashtra. Pharmaceutical products are produced and sold by Piramal Pharma Limited. The business has a global and domestic serving area. Piramal Pharma&#8217;s global distribution network enables this Indian pharmaceutical company to have a significant impact on the international stage. PPL Pharma has manufacturing facilities in 17 locations around the world and more than 100 distribution networks worldwide.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Piramal_Pharma_Share_Price_Target_2025-2030\"><\/span>Piramal Pharma Share Price Target 2025-2030<span class=\"ez-toc-section-end\"><\/span><\/h2><div id=\"ez-toc-container\" class=\"ez-toc-v2_0_69_1 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Main Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #63d611;color:#63d611\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #63d611;color:#63d611\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/gaainfo.com\/piramal-pharma-share-price-target\/#Piramal_Pharma_Share_Price_Target_2025-2030\" title=\"Piramal Pharma Share Price Target 2025-2030\">Piramal Pharma Share Price Target 2025-2030<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/gaainfo.com\/piramal-pharma-share-price-target\/#Piramal_Pharma_Share_Price_Target_Today_Update\" title=\"Piramal Pharma Share Price Target Today Update\">Piramal Pharma Share Price Target Today Update<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/gaainfo.com\/piramal-pharma-share-price-target\/#Piramal_Pharma_Business_Profile\" title=\"Piramal Pharma Business Profile\">Piramal Pharma Business Profile<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/gaainfo.com\/piramal-pharma-share-price-target\/#India_Consumer_Healthcare\" title=\"India Consumer Healthcare\">India Consumer Healthcare<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/gaainfo.com\/piramal-pharma-share-price-target\/#Joint_Venture\" title=\"Joint Venture\">Joint Venture<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/gaainfo.com\/piramal-pharma-share-price-target\/#Piramal_Pharma_Fundamentals_Quarterly_Results\" title=\"Piramal Pharma Fundamentals &amp; Quarterly Results\">Piramal Pharma Fundamentals &amp; Quarterly Results<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/gaainfo.com\/piramal-pharma-share-price-target\/#Piramal_Pharma_Quarterly_Results\" title=\"Piramal Pharma Quarterly Results\">Piramal Pharma Quarterly Results<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/gaainfo.com\/piramal-pharma-share-price-target\/#CAGR_Report\" title=\"CAGR Report\">CAGR Report<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/gaainfo.com\/piramal-pharma-share-price-target\/#Piramal_Pharma_Shareholding_Pattern\" title=\"Piramal Pharma Shareholding Pattern\">Piramal Pharma Shareholding Pattern<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/gaainfo.com\/piramal-pharma-share-price-target\/#Piramal_Pharma_Share_Price_Target_2025-2030_Forecast\" title=\"Piramal Pharma Share Price Target 2025-2030 Forecast\">Piramal Pharma Share Price Target 2025-2030 Forecast<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/gaainfo.com\/piramal-pharma-share-price-target\/#Piramal_Pharma_Share_Price_Target_2025\" title=\"Piramal Pharma Share Price Target 2025\">Piramal Pharma Share Price Target 2025<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/gaainfo.com\/piramal-pharma-share-price-target\/#Piramal_Pharma_Share_Price_Target_2026\" title=\"Piramal Pharma Share Price Target 2026\">Piramal Pharma Share Price Target 2026<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/gaainfo.com\/piramal-pharma-share-price-target\/#Piramal_Pharma_Share_Price_Target_2027\" title=\"Piramal Pharma Share Price Target 2027\">Piramal Pharma Share Price Target 2027<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/gaainfo.com\/piramal-pharma-share-price-target\/#Piramal_Pharma_Share_Price_Target_2028\" title=\"Piramal Pharma Share Price Target 2028\">Piramal Pharma Share Price Target 2028<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/gaainfo.com\/piramal-pharma-share-price-target\/#Piramal_Pharma_Share_Price_Target_2029\" title=\"Piramal Pharma Share Price Target 2029\">Piramal Pharma Share Price Target 2029<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/gaainfo.com\/piramal-pharma-share-price-target\/#BPCL_Share_Price_Target_2030\" title=\"BPCL Share Price Target 2030\">BPCL Share Price Target 2030<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/gaainfo.com\/piramal-pharma-share-price-target\/#Points_Before_Investing_in_Piramal_Pharma_Stock\" title=\"Points Before Investing in Piramal Pharma Stock\">Points Before Investing in Piramal Pharma Stock<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/gaainfo.com\/piramal-pharma-share-price-target\/#Final_Words\" title=\"Final Words\">Final Words<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n\n<p>Piramal Pharma is an essential component of the Mumbai, Maharashtra-based Piramal business Group. Their pharmaceuticals are manufactured and distributed by this company. This service provider has a global and local presence everywhere. This has made Piramal Pharma significant on a global scale everywhere. Piramal Pharma is a global company that manufactures one-of-a-kind goods and provides customers with a comprehensive array of pharmaceutical services.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Piramal_Pharma_Share_Price_Target_Today_Update\"><\/span>Piramal Pharma Share Price Target Today Update<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<ul>\n<li>Piramal Pharma&#8217;s share price today began at Rs 123.55 per share, and the stock has shown no signs of fluctuation on the stock market throughout the day. The US Food and Drug Administration (FDA) recently granted Piramal Pharma company approval for its Lexington facility.<\/li>\n<li>After conducting an inspection at the Piramal Pharma Lexington Plant, authorities made two observations. Nandini Piramal, chairperson of Piramal Pharma, revealed the company&#8217;s plan to invest Rs 1,000 crore over the next 18 months to boost the business&#8217;s growth.<\/li>\n<li>In the interview that took place on December 8, 2023, Nandini Piramal provided a more in-depth explanation of the means by which the business would make investments to maintain its growth rate and increase its brownfield capacity.<\/li>\n<\/ul>\n<p><strong>Check Here:-<\/strong><\/p>\n<p><a href=\"https:\/\/gaainfo.com\/adani-ports-share-price-target\/\"><u>Adani Ports Share Price Target<\/u><\/a><\/p>\n<p><a href=\"https:\/\/gaainfo.com\/samvardhana-motherson-share-price-target\/\"><u>Samvardhana Motherson Share Price Target<\/u><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Piramal_Pharma_Business_Profile\"><\/span>Piramal Pharma Business Profile<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Piramal Pharma Limited (PPL) is one of the Piramal group&#8217;s businesses. The company entered the pharmaceutical industry in 1988 by purchasing Nicholas Laboratories, which it expanded through various strategies, including mergers and acquisitions. The company sold its local formulations division to Abott for USD 3.7 billion this year, and Super Religare Laboratories purchased its diagnostics division (SRL).<\/p>\n<ul>\n<li><strong>CDMO:<\/strong> Three of the company&#8217;s 13 locations are in North America, two are in Europe, and seven are in India. The other two are used for the operation. It is one of the top three CDMO companies in the area, but when it comes to capabilities for both finished drugs and active pharmaceutical ingredients, it ranks 13th globally. The company has about 500 regular customers who live in various parts of the world.<\/li>\n<li><strong>CHG:<\/strong> Inhalation anesthesia, anesthesia and pain management, intrathecal therapy, and other injectables are just a few of the company&#8217;s product categories. It is the world&#8217;s fourth-largest manufacturer of inhaled anesthesia. More than 6,000 hospitals are among its customers. The item portfolio comprises of in excess of 40 contributions, which are gathered as follows; Inward breath Sedation (58%), Injectable Sedation and torment the board (17%), Intrathecal Treatment (16%), and different items (9%).<\/li>\n<\/ul>\n<h3><span class=\"ez-toc-section\" id=\"India_Consumer_Healthcare\"><\/span>India Consumer Healthcare<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Through this globalization strategy, the company owns diverse assets of vertically integrated manufacturing capabilities, allowing it to launch 13 of its development SKUs and simultaneously have 11 filed, 13 under development, and as many as 13 yet-to-be-unveiled products. The domain that the company controls spans over 100 nations.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Joint_Venture\"><\/span>Joint Venture<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>This organization has a 49% possession interest in a joint endeavor with Allergan India Pvt. Ltd., one of India&#8217;s leading manufacturers of ophthalmic formulations (Avvyie, a US pharmaceutical company, owns 51% of the company). Glaucoma, dry eye, infections, and inflammation are areas where the company excels. Ozurdex, Combigan, Lumigan, Alphagan, and Predforte are important brands.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Piramal_Pharma_Fundamentals_Quarterly_Results\"><\/span>Piramal Pharma Fundamentals &amp; Quarterly Results<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<table style=\"height: 1250px;\" width=\"420\">\n<tbody>\n<tr>\n<td>Market Cap<\/td>\n<td>\u20b920,967 Cr.<\/td>\n<\/tr>\n<tr>\n<td>Current Price<\/td>\n<td>\u20b9158<\/td>\n<\/tr>\n<tr>\n<td>52 Week High\/Low<\/td>\n<td>\u20b9167 \/ \u20b987.5<\/td>\n<\/tr>\n<tr>\n<td>Stock P\/E<\/td>\n<td>1,335<\/td>\n<\/tr>\n<tr>\n<td>Book Value<\/td>\n<td>\u20b959.8<\/td>\n<\/tr>\n<tr>\n<td>Dividend Yield<\/td>\n<td>0.07%<\/td>\n<\/tr>\n<tr>\n<td>ROCE<\/td>\n<td>5.52%<\/td>\n<\/tr>\n<tr>\n<td>ROE<\/td>\n<td>0.21%<\/td>\n<\/tr>\n<tr>\n<td>Face Value<\/td>\n<td>\u20b910.0<\/td>\n<\/tr>\n<tr>\n<td>Debt to Equity<\/td>\n<td>0.60<\/td>\n<\/tr>\n<tr>\n<td>Debt Preceding Year<\/td>\n<td>\u20b95,637 Cr.<\/td>\n<\/tr>\n<tr>\n<td>Current Debt<\/td>\n<td>\u20b94,710 Cr.<\/td>\n<\/tr>\n<tr>\n<td>Reserves<\/td>\n<td>\u20b96,588 Cr.<\/td>\n<\/tr>\n<tr>\n<td>EPS<\/td>\n<td>\u20b90.13<\/td>\n<\/tr>\n<tr>\n<td>EPS Last Year<\/td>\n<td>\u20b90.13<\/td>\n<\/tr>\n<tr>\n<td>Pledged Percentage<\/td>\n<td>0.00%<\/td>\n<\/tr>\n<tr>\n<td>FCF Previous Annual<\/td>\n<td>\u20b9 -461 Cr.<\/td>\n<\/tr>\n<tr>\n<td>EV\/EBITDA<\/td>\n<td>17.6<\/td>\n<\/tr>\n<tr>\n<td>Industry P\/E<\/td>\n<td>36.2<\/td>\n<\/tr>\n<tr>\n<td>Piotroski Score<\/td>\n<td>9.00<\/td>\n<\/tr>\n<tr>\n<td>Earnings Yield<\/td>\n<td>2.72%<\/td>\n<\/tr>\n<tr>\n<td>Sales Growth 5 Years<\/td>\n<td>Not Provided<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Check Here:-<\/strong><\/p>\n<p><a href=\"https:\/\/gaainfo.com\/tata-investment-share-price-target\/\"><u>Tata Investment Share Price Target<\/u><\/a><\/p>\n<p><a href=\"https:\/\/gaainfo.com\/mazagon-dock-share-price-target\/\"><u>Mazagon Dock Share Price Target<\/u><\/a><\/p>\n<h3><span class=\"ez-toc-section\" id=\"Piramal_Pharma_Quarterly_Results\"><\/span>Piramal Pharma Quarterly Results<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<table>\n<tbody>\n<tr>\n<td>Quarter<\/td>\n<td>Jun 2022<\/td>\n<td>Sep 2022<\/td>\n<td>Dec 2022<\/td>\n<td>Mar 2023<\/td>\n<td>Jun 2023<\/td>\n<td>Sep 2023<\/td>\n<td>Dec 2023<\/td>\n<td>Mar 2025<\/td>\n<\/tr>\n<tr>\n<td>Sales<\/td>\n<td>1,482<\/td>\n<td>1,720<\/td>\n<td>1,716<\/td>\n<td>2,164<\/td>\n<td>1,749<\/td>\n<td>1,911<\/td>\n<td>1,959<\/td>\n<td>2,552<\/td>\n<\/tr>\n<tr>\n<td>Expenses<\/td>\n<td>1,465<\/td>\n<td>1,547<\/td>\n<td>1,629<\/td>\n<td>1,812<\/td>\n<td>1,617<\/td>\n<td>1,646<\/td>\n<td>1,690<\/td>\n<td>2,022<\/td>\n<\/tr>\n<tr>\n<td>Operating Profit<\/td>\n<td>17<\/td>\n<td>173<\/td>\n<td>87<\/td>\n<td>351<\/td>\n<td>132<\/td>\n<td>266<\/td>\n<td>268<\/td>\n<td>530<\/td>\n<\/tr>\n<tr>\n<td>OPM %<\/td>\n<td>1%<\/td>\n<td>10%<\/td>\n<td>5%<\/td>\n<td>16%<\/td>\n<td>8%<\/td>\n<td>14%<\/td>\n<td>14%<\/td>\n<td>21%<\/td>\n<\/tr>\n<tr>\n<td>Other Income<\/td>\n<td>92<\/td>\n<td>50<\/td>\n<td>98<\/td>\n<td>32<\/td>\n<td>53<\/td>\n<td>68<\/td>\n<td>43<\/td>\n<td>8<\/td>\n<\/tr>\n<tr>\n<td>Interest<\/td>\n<td>62<\/td>\n<td>83<\/td>\n<td>95<\/td>\n<td>104<\/td>\n<td>119<\/td>\n<td>110<\/td>\n<td>106<\/td>\n<td>114<\/td>\n<\/tr>\n<tr>\n<td>Depreciation<\/td>\n<td>162<\/td>\n<td>166<\/td>\n<td>164<\/td>\n<td>184<\/td>\n<td>174<\/td>\n<td>185<\/td>\n<td>186<\/td>\n<td>196<\/td>\n<\/tr>\n<tr>\n<td>Profit before tax<\/td>\n<td>-115<\/td>\n<td>-26<\/td>\n<td>-74<\/td>\n<td>95<\/td>\n<td>-107<\/td>\n<td>40<\/td>\n<td>19<\/td>\n<td>227<\/td>\n<\/tr>\n<tr>\n<td>Tax %<\/td>\n<td>5%<\/td>\n<td>-42%<\/td>\n<td>-22%<\/td>\n<td>47%<\/td>\n<td>8%<\/td>\n<td>87%<\/td>\n<td>48%<\/td>\n<td>55%<\/td>\n<\/tr>\n<tr>\n<td>Net Profit<\/td>\n<td>-109<\/td>\n<td>-37<\/td>\n<td>-90<\/td>\n<td>50<\/td>\n<td>-99<\/td>\n<td>5<\/td>\n<td>10<\/td>\n<td>101<\/td>\n<\/tr>\n<tr>\n<td>EPS in Rs<\/td>\n<td><\/td>\n<td>-0.28<\/td>\n<td>-0.68<\/td>\n<td>0.38<\/td>\n<td>-0.75<\/td>\n<td>0.04<\/td>\n<td>0.08<\/td>\n<td>0.77<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h3><span class=\"ez-toc-section\" id=\"CAGR_Report\"><\/span>CAGR Report<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<table>\n<tbody>\n<tr>\n<td>Metric<\/td>\n<td>10 Years<\/td>\n<td>5 Years<\/td>\n<td>3 Years<\/td>\n<td>TTM<\/td>\n<td>1 Year<\/td>\n<\/tr>\n<tr>\n<td>Compounded Sales Growth<\/td>\n<td>\u2013<\/td>\n<td>\u2013<\/td>\n<td>9%<\/td>\n<td>15%<\/td>\n<td>\u2013<\/td>\n<\/tr>\n<tr>\n<td>Compounded Profit Growth<\/td>\n<td>\u2013<\/td>\n<td>\u2013<\/td>\n<td>-73%<\/td>\n<td>108%<\/td>\n<td>\u2013<\/td>\n<\/tr>\n<tr>\n<td>Stock Price CAGR<\/td>\n<td>\u2013<\/td>\n<td>\u2013<\/td>\n<td>\u2013<\/td>\n<td>\u2013<\/td>\n<td>76%<\/td>\n<\/tr>\n<tr>\n<td>Return on Equity<\/td>\n<td>\u2013<\/td>\n<td>\u2013<\/td>\n<td>1%<\/td>\n<td>\u2013<\/td>\n<td>0%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h3><span class=\"ez-toc-section\" id=\"Piramal_Pharma_Shareholding_Pattern\"><\/span>Piramal Pharma Shareholding Pattern<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<table>\n<tbody>\n<tr>\n<td>Quarter<\/td>\n<td>Dec 2022<\/td>\n<td>Mar 2023<\/td>\n<td>Jun 2023<\/td>\n<td>Sep 2023<\/td>\n<td>Dec 2023<\/td>\n<td>Mar 2025<\/td>\n<\/tr>\n<tr>\n<td>Promoters<\/td>\n<td>34.78%<\/td>\n<td>34.78%<\/td>\n<td>34.78%<\/td>\n<td>35.02%<\/td>\n<td>35.02%<\/td>\n<td>35.02%<\/td>\n<\/tr>\n<tr>\n<td>FIIs<\/td>\n<td>41.29%<\/td>\n<td>39.28%<\/td>\n<td>35.01%<\/td>\n<td>32.37%<\/td>\n<td>32.51%<\/td>\n<td>30.58%<\/td>\n<\/tr>\n<tr>\n<td>DIIs<\/td>\n<td>5.26%<\/td>\n<td>4.98%<\/td>\n<td>5.48%<\/td>\n<td>8.01%<\/td>\n<td>9.68%<\/td>\n<td>12.12%<\/td>\n<\/tr>\n<tr>\n<td>Public<\/td>\n<td>18.27%<\/td>\n<td>20.57%<\/td>\n<td>24.32%<\/td>\n<td>24.21%<\/td>\n<td>22.41%<\/td>\n<td>21.89%<\/td>\n<\/tr>\n<tr>\n<td>Others<\/td>\n<td>0.39%<\/td>\n<td>0.39%<\/td>\n<td>0.39%<\/td>\n<td>0.38%<\/td>\n<td>0.38%<\/td>\n<td>0.37%<\/td>\n<\/tr>\n<tr>\n<td>No. of Shareholders<\/td>\n<td>2,29,960<\/td>\n<td>2,41,359<\/td>\n<td>2,77,270<\/td>\n<td>3,00,606<\/td>\n<td>2,92,312<\/td>\n<td>2,97,996<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h3><span class=\"ez-toc-section\" id=\"Piramal_Pharma_Share_Price_Target_2025-2030_Forecast\"><\/span>Piramal Pharma Share Price Target 2025-2030 Forecast<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<table style=\"height: 422px;\" width=\"533\">\n<tbody>\n<tr>\n<td>Year<\/td>\n<td>Initial Target<\/td>\n<\/tr>\n<tr>\n<td>2025<\/td>\n<td>200<\/td>\n<\/tr>\n<tr>\n<td>2025<\/td>\n<td>261<\/td>\n<\/tr>\n<tr>\n<td>2026<\/td>\n<td>326<\/td>\n<\/tr>\n<tr>\n<td>2027<\/td>\n<td>367<\/td>\n<\/tr>\n<tr>\n<td>2028<\/td>\n<td>420<\/td>\n<\/tr>\n<tr>\n<td>2029<\/td>\n<td>479<\/td>\n<\/tr>\n<tr>\n<td>2030<\/td>\n<td>530<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h3><span class=\"ez-toc-section\" id=\"Piramal_Pharma_Share_Price_Target_2025\"><\/span>Piramal Pharma Share Price Target 2025<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<table style=\"height: 739px;\" width=\"552\">\n<tbody>\n<tr>\n<td>Month<\/td>\n<td>Target<\/td>\n<\/tr>\n<tr>\n<td>January<\/td>\n<td>213<\/td>\n<\/tr>\n<tr>\n<td>February<\/td>\n<td>207<\/td>\n<\/tr>\n<tr>\n<td>March<\/td>\n<td>199<\/td>\n<\/tr>\n<tr>\n<td>April<\/td>\n<td>205<\/td>\n<\/tr>\n<tr>\n<td>May<\/td>\n<td>211<\/td>\n<\/tr>\n<tr>\n<td>June<\/td>\n<td>225<\/td>\n<\/tr>\n<tr>\n<td>July<\/td>\n<td>233<\/td>\n<\/tr>\n<tr>\n<td>August<\/td>\n<td>245<\/td>\n<\/tr>\n<tr>\n<td>September<\/td>\n<td>257<\/td>\n<\/tr>\n<tr>\n<td>October<\/td>\n<td>248<\/td>\n<\/tr>\n<tr>\n<td>November<\/td>\n<td>256<\/td>\n<\/tr>\n<tr>\n<td>December<\/td>\n<td>261<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h3><span class=\"ez-toc-section\" id=\"Piramal_Pharma_Share_Price_Target_2026\"><\/span>Piramal Pharma Share Price Target 2026<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<table style=\"height: 728px;\" width=\"452\">\n<tbody>\n<tr>\n<td>Month<\/td>\n<td>Target<\/td>\n<\/tr>\n<tr>\n<td>January<\/td>\n<td>267<\/td>\n<\/tr>\n<tr>\n<td>February<\/td>\n<td>260<\/td>\n<\/tr>\n<tr>\n<td>March<\/td>\n<td>254<\/td>\n<\/tr>\n<tr>\n<td>April<\/td>\n<td>262<\/td>\n<\/tr>\n<tr>\n<td>May<\/td>\n<td>274<\/td>\n<\/tr>\n<tr>\n<td>June<\/td>\n<td>287<\/td>\n<\/tr>\n<tr>\n<td>July<\/td>\n<td>296<\/td>\n<\/tr>\n<tr>\n<td>August<\/td>\n<td>309<\/td>\n<\/tr>\n<tr>\n<td>September<\/td>\n<td>315<\/td>\n<\/tr>\n<tr>\n<td>October<\/td>\n<td>311<\/td>\n<\/tr>\n<tr>\n<td>November<\/td>\n<td>319<\/td>\n<\/tr>\n<tr>\n<td>December<\/td>\n<td>326<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h3><span class=\"ez-toc-section\" id=\"Piramal_Pharma_Share_Price_Target_2027\"><\/span>Piramal Pharma Share Price Target 2027<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<table style=\"height: 711px;\" width=\"521\">\n<tbody>\n<tr>\n<td>Month<\/td>\n<td width=\"83\">Target<\/td>\n<\/tr>\n<tr>\n<td>January<\/td>\n<td width=\"83\">325<\/td>\n<\/tr>\n<tr>\n<td>February<\/td>\n<td width=\"83\">319<\/td>\n<\/tr>\n<tr>\n<td>March<\/td>\n<td width=\"83\">312<\/td>\n<\/tr>\n<tr>\n<td>April<\/td>\n<td width=\"83\">318<\/td>\n<\/tr>\n<tr>\n<td>May<\/td>\n<td width=\"83\">328<\/td>\n<\/tr>\n<tr>\n<td>June<\/td>\n<td width=\"83\">337<\/td>\n<\/tr>\n<tr>\n<td>July<\/td>\n<td width=\"83\">344<\/td>\n<\/tr>\n<tr>\n<td>August<\/td>\n<td width=\"83\">357<\/td>\n<\/tr>\n<tr>\n<td>September<\/td>\n<td width=\"83\">350<\/td>\n<\/tr>\n<tr>\n<td>October<\/td>\n<td width=\"83\">345<\/td>\n<\/tr>\n<tr>\n<td>November<\/td>\n<td width=\"83\">353<\/td>\n<\/tr>\n<tr>\n<td>December<\/td>\n<td width=\"83\">367<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h3><span class=\"ez-toc-section\" id=\"Piramal_Pharma_Share_Price_Target_2028\"><\/span>Piramal Pharma Share Price Target 2028<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<table style=\"height: 715px;\" width=\"510\">\n<tbody>\n<tr>\n<td>Month<\/td>\n<td>Target<\/td>\n<\/tr>\n<tr>\n<td>January<\/td>\n<td>375<\/td>\n<\/tr>\n<tr>\n<td>February<\/td>\n<td>368<\/td>\n<\/tr>\n<tr>\n<td>March<\/td>\n<td>362<\/td>\n<\/tr>\n<tr>\n<td>April<\/td>\n<td>340<\/td>\n<\/tr>\n<tr>\n<td>May<\/td>\n<td>345<\/td>\n<\/tr>\n<tr>\n<td>June<\/td>\n<td>360<\/td>\n<\/tr>\n<tr>\n<td>July<\/td>\n<td>385<\/td>\n<\/tr>\n<tr>\n<td>August<\/td>\n<td>400<\/td>\n<\/tr>\n<tr>\n<td>September<\/td>\n<td>396<\/td>\n<\/tr>\n<tr>\n<td>October<\/td>\n<td>406<\/td>\n<\/tr>\n<tr>\n<td>November<\/td>\n<td>412<\/td>\n<\/tr>\n<tr>\n<td>December<\/td>\n<td>420<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Check Here:-<\/p>\n<p><a href=\"https:\/\/gaainfo.com\/bank-of-india-share-price-target\/\"><u>Bank Of India Share Price Target<\/u><\/a><\/p>\n<p><a href=\"https:\/\/gaainfo.com\/wockhardt-share-price-target\/\"><u>Wockhardt Share Price Target<\/u><\/a><\/p>\n<h3><span class=\"ez-toc-section\" id=\"Piramal_Pharma_Share_Price_Target_2029\"><\/span>Piramal Pharma Share Price Target 2029<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<table style=\"height: 731px;\" width=\"442\">\n<tbody>\n<tr>\n<td>Month<\/td>\n<td>Target<\/td>\n<\/tr>\n<tr>\n<td>January<\/td>\n<td>429<\/td>\n<\/tr>\n<tr>\n<td>February<\/td>\n<td>421<\/td>\n<\/tr>\n<tr>\n<td>March<\/td>\n<td>415<\/td>\n<\/tr>\n<tr>\n<td>April<\/td>\n<td>390<\/td>\n<\/tr>\n<tr>\n<td>May<\/td>\n<td>405<\/td>\n<\/tr>\n<tr>\n<td>June<\/td>\n<td>419<\/td>\n<\/tr>\n<tr>\n<td>July<\/td>\n<td>430<\/td>\n<\/tr>\n<tr>\n<td>August<\/td>\n<td>441<\/td>\n<\/tr>\n<tr>\n<td>September<\/td>\n<td>459<\/td>\n<\/tr>\n<tr>\n<td>October<\/td>\n<td>455<\/td>\n<\/tr>\n<tr>\n<td>November<\/td>\n<td>467<\/td>\n<\/tr>\n<tr>\n<td>December<\/td>\n<td>479<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h3><span class=\"ez-toc-section\" id=\"BPCL_Share_Price_Target_2030\"><\/span>BPCL Share Price Target 2030<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<table style=\"height: 742px;\" width=\"629\">\n<tbody>\n<tr>\n<td>Month<\/td>\n<td>Target<\/td>\n<\/tr>\n<tr>\n<td>January<\/td>\n<td>489<\/td>\n<\/tr>\n<tr>\n<td>February<\/td>\n<td>470<\/td>\n<\/tr>\n<tr>\n<td>March<\/td>\n<td>450<\/td>\n<\/tr>\n<tr>\n<td>April<\/td>\n<td>458<\/td>\n<\/tr>\n<tr>\n<td>May<\/td>\n<td>478<\/td>\n<\/tr>\n<tr>\n<td>June<\/td>\n<td>490<\/td>\n<\/tr>\n<tr>\n<td>July<\/td>\n<td>500<\/td>\n<\/tr>\n<tr>\n<td>August<\/td>\n<td>511<\/td>\n<\/tr>\n<tr>\n<td>September<\/td>\n<td>520<\/td>\n<\/tr>\n<tr>\n<td>October<\/td>\n<td>513<\/td>\n<\/tr>\n<tr>\n<td>November<\/td>\n<td>521<\/td>\n<\/tr>\n<tr>\n<td>December<\/td>\n<td>530<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h3><span class=\"ez-toc-section\" id=\"Points_Before_Investing_in_Piramal_Pharma_Stock\"><\/span>Points Before Investing in Piramal Pharma Stock<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<ul>\n<li>India&#8217;s and the world&#8217;s pharmaceutical industries are huge, and the potential Indian market and its manufacturers make things even more interesting for investors in pharmaceutical companies.<\/li>\n<li>In its December quarter (Q3 FY24), Piramal Pharma Ltd. reported a net profit of Rs 10.11 crores and revenue growth of 14% year over year.<\/li>\n<li>Piramal Pharma&#8217;s EBIDTA was reported at Rs. 330 crores, representing a 94% annual growth rate. PPL Pharma had an Ebidta Margin of 17%.<\/li>\n<li>These results point to the company&#8217;s overall efficiency as well as other factors like lower raw material costs.<\/li>\n<li>Piramal Pharma Offer Cost target is set at Rs 165 and the Motilal Oswal dealer firm and offer market master has kept up with its &#8220;&#8216;Purchase&#8221; status for the NSE PPL Pharma&#8217; in its proclamation toward the beginning of February 2025.<\/li>\n<\/ul>\n<h3><span class=\"ez-toc-section\" id=\"Final_Words\"><\/span>Final Words<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The Piramal Pharma Share Price history recommends us an entirely unsound nature of the stock. NSE PPL Pharma stock went from Rs 169 as its opening price point to Rs 62 per share just six months after it was listed on the stock exchange. This occurred in just one year and seven months of trading on the stock exchange. However, the Piramal Pharma Share has been recovering since March 2023, when it reached its all-time low stock price. As of this writing, on March 12, 2025, the share is currently trading at Rs 123.35 per share.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Piramal Group of businesses includes Piramal Pharma, which is registered in Mumbai, Maharashtra. Pharmaceutical products are produced and sold by Piramal Pharma Limited. The business has a global and domestic serving area. Piramal Pharma&#8217;s global distribution network enables this Indian pharmaceutical company to have a significant impact on the international stage. PPL Pharma has &#8230; <a title=\"Piramal Pharma Share Price Target 2025-2030 Today Update, Business Profile, Fundamentals &#038; Quarterly Results\" class=\"read-more\" href=\"https:\/\/gaainfo.com\/piramal-pharma-share-price-target\/\" aria-label=\"Read more about Piramal Pharma Share Price Target 2025-2030 Today Update, Business Profile, Fundamentals &#038; Quarterly Results\">Read more<\/a><\/p>\n","protected":false},"author":2,"featured_media":1633,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[13],"tags":[],"class_list":["post-1618","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-stocks"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Piramal Pharma Share Price Target 2025-2030 Today Update, Business Profile, Fundamentals &amp; Quarterly Results - Gaainfo<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/gaainfo.com\/piramal-pharma-share-price-target\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Piramal Pharma Share Price Target 2025-2030 Today Update, Business Profile, Fundamentals &amp; Quarterly Results - Gaainfo\" \/>\n<meta property=\"og:description\" content=\"The Piramal Group of businesses includes Piramal Pharma, which is registered in Mumbai, Maharashtra. Pharmaceutical products are produced and sold by Piramal Pharma Limited. The business has a global and domestic serving area. Piramal Pharma&#8217;s global distribution network enables this Indian pharmaceutical company to have a significant impact on the international stage. PPL Pharma has ... Read more\" \/>\n<meta property=\"og:url\" content=\"https:\/\/gaainfo.com\/piramal-pharma-share-price-target\/\" \/>\n<meta property=\"og:site_name\" content=\"Gaainfo\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-26T05:49:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/gaainfo.com\/wp-content\/uploads\/2024\/08\/Piramal-Pharma-Share-Price-Target-Today-Update.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Oliver\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Oliver\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/gaainfo.com\/piramal-pharma-share-price-target\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/gaainfo.com\/piramal-pharma-share-price-target\/\"},\"author\":{\"name\":\"Oliver\",\"@id\":\"https:\/\/gaainfo.com\/#\/schema\/person\/8db315b428de933a19815c7768965eae\"},\"headline\":\"Piramal Pharma Share Price Target 2025-2030 Today Update, Business Profile, Fundamentals &#038; Quarterly Results\",\"datePublished\":\"2025-01-26T05:49:43+00:00\",\"dateModified\":\"2025-01-26T05:49:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/gaainfo.com\/piramal-pharma-share-price-target\/\"},\"wordCount\":1114,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/gaainfo.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/gaainfo.com\/piramal-pharma-share-price-target\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/gaainfo.com\/wp-content\/uploads\/2024\/08\/Piramal-Pharma-Share-Price-Target-Today-Update.jpg\",\"articleSection\":[\"Stocks\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/gaainfo.com\/piramal-pharma-share-price-target\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/gaainfo.com\/piramal-pharma-share-price-target\/\",\"url\":\"https:\/\/gaainfo.com\/piramal-pharma-share-price-target\/\",\"name\":\"Piramal Pharma Share Price Target 2025-2030 Today Update, Business Profile, Fundamentals & Quarterly Results - Gaainfo\",\"isPartOf\":{\"@id\":\"https:\/\/gaainfo.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/gaainfo.com\/piramal-pharma-share-price-target\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/gaainfo.com\/piramal-pharma-share-price-target\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/gaainfo.com\/wp-content\/uploads\/2024\/08\/Piramal-Pharma-Share-Price-Target-Today-Update.jpg\",\"datePublished\":\"2025-01-26T05:49:43+00:00\",\"dateModified\":\"2025-01-26T05:49:43+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/gaainfo.com\/piramal-pharma-share-price-target\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/gaainfo.com\/piramal-pharma-share-price-target\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/gaainfo.com\/piramal-pharma-share-price-target\/#primaryimage\",\"url\":\"https:\/\/gaainfo.com\/wp-content\/uploads\/2024\/08\/Piramal-Pharma-Share-Price-Target-Today-Update.jpg\",\"contentUrl\":\"https:\/\/gaainfo.com\/wp-content\/uploads\/2024\/08\/Piramal-Pharma-Share-Price-Target-Today-Update.jpg\",\"width\":800,\"height\":800,\"caption\":\"Piramal Pharma Share Price Target Today Update\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/gaainfo.com\/piramal-pharma-share-price-target\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/gaainfo.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Piramal Pharma Share Price Target 2025-2030 Today Update, Business Profile, Fundamentals &#038; Quarterly Results\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/gaainfo.com\/#website\",\"url\":\"https:\/\/gaainfo.com\/\",\"name\":\"Gaainfo\",\"description\":\"Tech, Result, Sports, Live News\",\"publisher\":{\"@id\":\"https:\/\/gaainfo.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/gaainfo.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/gaainfo.com\/#organization\",\"name\":\"Gaainfo\",\"url\":\"https:\/\/gaainfo.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/gaainfo.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/gaainfo.com\/wp-content\/uploads\/2024\/08\/cropped-Gaainfo-Logo.png\",\"contentUrl\":\"https:\/\/gaainfo.com\/wp-content\/uploads\/2024\/08\/cropped-Gaainfo-Logo.png\",\"width\":387,\"height\":320,\"caption\":\"Gaainfo\"},\"image\":{\"@id\":\"https:\/\/gaainfo.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/gaainfo.com\/#\/schema\/person\/8db315b428de933a19815c7768965eae\",\"name\":\"Oliver\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/gaainfo.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/fde348eb89f6a71493cd2d956aa938da?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/fde348eb89f6a71493cd2d956aa938da?s=96&d=mm&r=g\",\"caption\":\"Oliver\"},\"url\":\"https:\/\/gaainfo.com\/author\/oliver\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Piramal Pharma Share Price Target 2025-2030 Today Update, Business Profile, Fundamentals & Quarterly Results - Gaainfo","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/gaainfo.com\/piramal-pharma-share-price-target\/","og_locale":"en_US","og_type":"article","og_title":"Piramal Pharma Share Price Target 2025-2030 Today Update, Business Profile, Fundamentals & Quarterly Results - Gaainfo","og_description":"The Piramal Group of businesses includes Piramal Pharma, which is registered in Mumbai, Maharashtra. Pharmaceutical products are produced and sold by Piramal Pharma Limited. The business has a global and domestic serving area. Piramal Pharma&#8217;s global distribution network enables this Indian pharmaceutical company to have a significant impact on the international stage. PPL Pharma has ... Read more","og_url":"https:\/\/gaainfo.com\/piramal-pharma-share-price-target\/","og_site_name":"Gaainfo","article_published_time":"2025-01-26T05:49:43+00:00","og_image":[{"width":800,"height":800,"url":"https:\/\/gaainfo.com\/wp-content\/uploads\/2024\/08\/Piramal-Pharma-Share-Price-Target-Today-Update.jpg","type":"image\/jpeg"}],"author":"Oliver","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Oliver","Est. reading time":"7 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/gaainfo.com\/piramal-pharma-share-price-target\/#article","isPartOf":{"@id":"https:\/\/gaainfo.com\/piramal-pharma-share-price-target\/"},"author":{"name":"Oliver","@id":"https:\/\/gaainfo.com\/#\/schema\/person\/8db315b428de933a19815c7768965eae"},"headline":"Piramal Pharma Share Price Target 2025-2030 Today Update, Business Profile, Fundamentals &#038; Quarterly Results","datePublished":"2025-01-26T05:49:43+00:00","dateModified":"2025-01-26T05:49:43+00:00","mainEntityOfPage":{"@id":"https:\/\/gaainfo.com\/piramal-pharma-share-price-target\/"},"wordCount":1114,"commentCount":0,"publisher":{"@id":"https:\/\/gaainfo.com\/#organization"},"image":{"@id":"https:\/\/gaainfo.com\/piramal-pharma-share-price-target\/#primaryimage"},"thumbnailUrl":"https:\/\/gaainfo.com\/wp-content\/uploads\/2024\/08\/Piramal-Pharma-Share-Price-Target-Today-Update.jpg","articleSection":["Stocks"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/gaainfo.com\/piramal-pharma-share-price-target\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/gaainfo.com\/piramal-pharma-share-price-target\/","url":"https:\/\/gaainfo.com\/piramal-pharma-share-price-target\/","name":"Piramal Pharma Share Price Target 2025-2030 Today Update, Business Profile, Fundamentals & Quarterly Results - Gaainfo","isPartOf":{"@id":"https:\/\/gaainfo.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/gaainfo.com\/piramal-pharma-share-price-target\/#primaryimage"},"image":{"@id":"https:\/\/gaainfo.com\/piramal-pharma-share-price-target\/#primaryimage"},"thumbnailUrl":"https:\/\/gaainfo.com\/wp-content\/uploads\/2024\/08\/Piramal-Pharma-Share-Price-Target-Today-Update.jpg","datePublished":"2025-01-26T05:49:43+00:00","dateModified":"2025-01-26T05:49:43+00:00","breadcrumb":{"@id":"https:\/\/gaainfo.com\/piramal-pharma-share-price-target\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/gaainfo.com\/piramal-pharma-share-price-target\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/gaainfo.com\/piramal-pharma-share-price-target\/#primaryimage","url":"https:\/\/gaainfo.com\/wp-content\/uploads\/2024\/08\/Piramal-Pharma-Share-Price-Target-Today-Update.jpg","contentUrl":"https:\/\/gaainfo.com\/wp-content\/uploads\/2024\/08\/Piramal-Pharma-Share-Price-Target-Today-Update.jpg","width":800,"height":800,"caption":"Piramal Pharma Share Price Target Today Update"},{"@type":"BreadcrumbList","@id":"https:\/\/gaainfo.com\/piramal-pharma-share-price-target\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/gaainfo.com\/"},{"@type":"ListItem","position":2,"name":"Piramal Pharma Share Price Target 2025-2030 Today Update, Business Profile, Fundamentals &#038; Quarterly Results"}]},{"@type":"WebSite","@id":"https:\/\/gaainfo.com\/#website","url":"https:\/\/gaainfo.com\/","name":"Gaainfo","description":"Tech, Result, Sports, Live News","publisher":{"@id":"https:\/\/gaainfo.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/gaainfo.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/gaainfo.com\/#organization","name":"Gaainfo","url":"https:\/\/gaainfo.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/gaainfo.com\/#\/schema\/logo\/image\/","url":"https:\/\/gaainfo.com\/wp-content\/uploads\/2024\/08\/cropped-Gaainfo-Logo.png","contentUrl":"https:\/\/gaainfo.com\/wp-content\/uploads\/2024\/08\/cropped-Gaainfo-Logo.png","width":387,"height":320,"caption":"Gaainfo"},"image":{"@id":"https:\/\/gaainfo.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/gaainfo.com\/#\/schema\/person\/8db315b428de933a19815c7768965eae","name":"Oliver","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/gaainfo.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/fde348eb89f6a71493cd2d956aa938da?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/fde348eb89f6a71493cd2d956aa938da?s=96&d=mm&r=g","caption":"Oliver"},"url":"https:\/\/gaainfo.com\/author\/oliver\/"}]}},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/gaainfo.com\/wp-content\/uploads\/2024\/08\/Piramal-Pharma-Share-Price-Target-Today-Update.jpg","_links":{"self":[{"href":"https:\/\/gaainfo.com\/wp-json\/wp\/v2\/posts\/1618"}],"collection":[{"href":"https:\/\/gaainfo.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/gaainfo.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/gaainfo.com\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/gaainfo.com\/wp-json\/wp\/v2\/comments?post=1618"}],"version-history":[{"count":4,"href":"https:\/\/gaainfo.com\/wp-json\/wp\/v2\/posts\/1618\/revisions"}],"predecessor-version":[{"id":1635,"href":"https:\/\/gaainfo.com\/wp-json\/wp\/v2\/posts\/1618\/revisions\/1635"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/gaainfo.com\/wp-json\/wp\/v2\/media\/1633"}],"wp:attachment":[{"href":"https:\/\/gaainfo.com\/wp-json\/wp\/v2\/media?parent=1618"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/gaainfo.com\/wp-json\/wp\/v2\/categories?post=1618"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/gaainfo.com\/wp-json\/wp\/v2\/tags?post=1618"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}